Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome.
Ho
Raymond
R
School of Pharmacy, University of California San Francisco, 94143-0622, USA.
Kayser
Steven R
SR
D000208:Acute Disease; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D003327:Coronary Disease / Q000188:drug therapy / Q000451:nursing*; D003328:Coronary Thrombosis / Q000451:nursing; D004562:Electrocardiography; D000077542:Eptifibatide; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced*; D015912:Thrombolytic Therapy / Q000009:adverse effects* / Q000451:nursing
D000925:Anticoagulants; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077542:Eptifibatide